CALCAGNO, Andrea
 Distribuzione geografica
Continente #
NA - Nord America 6.568
EU - Europa 3.476
AS - Asia 2.040
AF - Africa 432
SA - Sud America 213
OC - Oceania 111
Continente sconosciuto - Info sul continente non disponibili 15
Totale 12.855
Nazione #
US - Stati Uniti d'America 6.365
IT - Italia 1.162
CN - Cina 938
DE - Germania 453
FR - Francia 349
GB - Regno Unito 309
IN - India 203
BG - Bulgaria 179
VN - Vietnam 173
NL - Olanda 156
CA - Canada 155
JP - Giappone 136
ES - Italia 117
ZA - Sudafrica 117
AU - Australia 103
KR - Corea 98
BR - Brasile 97
RU - Federazione Russa 97
PL - Polonia 88
NG - Nigeria 78
IR - Iran 74
MA - Marocco 71
CZ - Repubblica Ceca 69
ID - Indonesia 64
TR - Turchia 62
CH - Svizzera 50
SE - Svezia 49
FI - Finlandia 46
HK - Hong Kong 46
IE - Irlanda 43
RO - Romania 43
CO - Colombia 42
AT - Austria 41
MX - Messico 41
TW - Taiwan 38
TH - Thailandia 37
GR - Grecia 33
UG - Uganda 32
PK - Pakistan 31
PH - Filippine 30
BE - Belgio 28
MY - Malesia 28
IL - Israele 25
PT - Portogallo 25
MK - Macedonia 24
CI - Costa d'Avorio 23
UA - Ucraina 23
CL - Cile 22
LV - Lettonia 21
AR - Argentina 20
ET - Etiopia 19
PE - Perù 18
KE - Kenya 17
DK - Danimarca 16
EG - Egitto 15
SG - Singapore 14
HU - Ungheria 11
AE - Emirati Arabi Uniti 9
DZ - Algeria 9
EU - Europa 9
RS - Serbia 9
TZ - Tanzania 9
LT - Lituania 8
NZ - Nuova Zelanda 8
HR - Croazia 7
NO - Norvegia 7
BF - Burkina Faso 6
GH - Ghana 6
JO - Giordania 6
CM - Camerun 5
VE - Venezuela 5
A1 - Anonimo 4
LB - Libano 4
MW - Malawi 4
SA - Arabia Saudita 4
SK - Slovacchia (Repubblica Slovacca) 4
ZW - Zimbabwe 4
CD - Congo 3
CY - Cipro 3
EC - Ecuador 3
IQ - Iraq 3
LU - Lussemburgo 3
PR - Porto Rico 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
BO - Bolivia 2
CU - Cuba 2
EE - Estonia 2
GA - Gabon 2
GE - Georgia 2
MD - Moldavia 2
MU - Mauritius 2
PY - Paraguay 2
QA - Qatar 2
UY - Uruguay 2
UZ - Uzbekistan 2
YE - Yemen 2
BD - Bangladesh 1
BJ - Benin 1
BT - Bhutan 1
Totale 12.840
Città #
Fairfield 704
Houston 461
Ashburn 404
Woodbridge 393
Santa Cruz 374
Seattle 356
Torino 349
Buffalo 341
Ann Arbor 260
Beijing 233
Wilmington 230
Cambridge 220
Shanghai 205
Shenyang 123
Turin 114
Dong Ket 112
Chicago 105
San Diego 104
Los Angeles 92
Warsaw 80
Columbus 75
Milan 72
Amsterdam 70
University Park 63
Pisa 55
Las Vegas 51
Mountain View 47
Ottawa 46
Boardman 45
Lagos 45
Wuhan 42
Levski 39
Chandler 37
Guangzhou 37
Hangzhou 35
New York 35
Bengaluru 34
Dublin 34
Helsinki 34
Paris 34
Temara 34
Phoenix 33
Dallas 31
Toronto 30
Miami 28
Nanjing 27
Rome 27
Muizenberg 26
Vienna 26
Istanbul 24
Nürnberg 24
Secaucus 24
Frankfurt am Main 23
San Jose 23
Tokyo 23
Clearwater 22
London 22
San Francisco 22
Lake Forest 21
São Paulo 21
Taipei 21
Riga 20
Jakarta 18
Melbourne 18
Seoul 18
Ankara 17
Athens 17
Boston 17
Fes 17
Changsha 16
Council Bluffs 16
Henderson 16
Johannesburg 16
Lima 16
Provo 16
Riva 16
Atlanta 15
Madrid 15
Baltimore 14
Bogotá 14
Mumbai 14
Padova 14
Abidjan 13
Leawood 13
Sopot 13
Tehran 13
Bangkok 12
Birmingham 12
Brisbane 12
Central 12
Duncan 12
Durban 12
Herndon 12
Rochester 12
Skopje 12
Vicenza 12
Washington 12
Buenos Aires 11
Guiyang 11
Jacksonville 11
Totale 7.279
Nome #
Antiviral activity of maraviroc plus mirtazapine in a low-risk HIV-negative patient with progressive multifocal leukoencephalopathy, file e27ce42d-4561-2581-e053-d805fe0acbaa 1.860
Pharmacokinetics and pharmacodynamics of antiretrovirals in the central nervous system., file e27ce427-48e2-2581-e053-d805fe0acbaa 476
Cardiac dysfunction in pauci symptomatic human immunodeficiency virus patients: a meta-analysis in the highly active antiretroviral therapy era, file e27ce427-fa86-2581-e053-d805fe0acbaa 413
High prevalence at computed coronary tomography of non-calcified plaques in asymptomatic HIV patients treated with HAART: A meta-analysis, file e27ce427-40cf-2581-e053-d805fe0acbaa 313
Pharmacokinetics and pharmacogenetics of anti-tubercular drugs: a tool for treatment optimization?, file e27ce42d-83f8-2581-e053-d805fe0acbaa 313
Inosine triphosphatase polymorphisms and ribavirin pharmacokinetics as determinants of ribavirin-associate anemia in patients receiving standard anti-HCV treatment., file e27ce426-edaf-2581-e053-d805fe0acbaa 290
Elimination half-life may explain the relative efficacy of boceprevir and telaprevir in the treatment of hepatitis C virus genotype 1., file e27ce426-fb81-2581-e053-d805fe0acbaa 281
Tenofovir coadministration is not associated with lower unboosted atazanavir plasma exposure in the clinical setting, file e27ce426-c733-2581-e053-d805fe0acbaa 269
A UPLC-MS-MS method for the simultaneous quantification of first-line antituberculars in plasma and in PBMCs, file e27ce427-8c10-2581-e053-d805fe0acbaa 258
HIV-1 Very Low Level Viremia is Associated with Virological Failure in HAART-treated Patients, file e27ce427-fa88-2581-e053-d805fe0acbaa 256
The outcome of HIV-positive late presenters according to detectable CMV DNA and anti-CMV treatment, file e27ce42e-dc35-2581-e053-d805fe0acbaa 246
Presence of EBV DNA in Cerebrospinal Fluid is Associated with Greater HIV RNA and Inflammation, file e27ce42f-3070-2581-e053-d805fe0acbaa 244
Acute HIV infection: Improved algorithms for HIV testing., file e27ce427-f50f-2581-e053-d805fe0acbaa 217
Disappearance of Renal Stones in an HIV-1-Infected Patient After Reduction of Atazanavir Dose., file e27ce427-0fcf-2581-e053-d805fe0acbaa 216
Louseborne relapsing fever among East African refugees, Italy, 2015, file e27ce428-b94d-2581-e053-d805fe0acbaa 194
Intracellular accumulation of ritonavir combined with different protease inhibitors and correlations between concentrations in plasma and peripheral blood mononuclear cells., file e27ce42a-2054-2581-e053-d805fe0acbaa 187
High interpatient variability of raltegravir CSF concentrations in HIV-positive patients: a pharmacogenetic analysis., file e27ce426-fdb2-2581-e053-d805fe0acbaa 183
A(H1N1)pdm09 hemagglutinin D222G and D222N variants are frequently harbored by patients requiring extracorporeal membrane oxygenation and advanced respiratory assistance for severe A(H1N1)pdm09 infection, file e27ce429-086c-2581-e053-d805fe0acbaa 175
Pharmacokinetics of 400 mg of raltegravir once daily in combination with atazanavir/ritonavir plus two nucleoside/nucleotide reverse transcriptase inhibitors., file e27ce42a-3e63-2581-e053-d805fe0acbaa 172
Effect of SNPs in human ABCB1 on daptomycin pharmacokinetics in Caucasian patients., file e27ce427-8c12-2581-e053-d805fe0acbaa 171
Cardiovascular disease in HIV patients: from bench to bedside and backwards, file e27ce427-460c-2581-e053-d805fe0acbaa 170
Dual antiretroviral therapies are effective and safe regimens in the central nervous system of neurologically symptomatic people living with HIV, file e27ce430-6596-2581-e053-d805fe0acbaa 160
Symptomatic cerebrospinal fluid HIV-1 escape with no resistance-associated mutations following low-level plasma viremia, file e27ce42d-83fb-2581-e053-d805fe0acbaa 159
Transcatheter aortic valve implantation in a 54-year-old patient with aggressive HIV., file e27ce429-0c12-2581-e053-d805fe0acbaa 150
Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update December 2014, file e27ce427-f7f3-2581-e053-d805fe0acbaa 147
Immune activation and microbial translocation in liver disease progression in HIV/hepatitis co-infected patients: results from the Icona Foundation study., file e27ce427-0fce-2581-e053-d805fe0acbaa 145
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9), file e27ce433-fc20-2581-e053-d805fe0acbaa 145
Estimating ribavirin plasma exposure: Genetics or therapeutic drug monitoring?, file e27ce426-e343-2581-e053-d805fe0acbaa 143
Early low-molecular-weight heparin administration is associated with shorter time to SARS-CoV-2 swab negativity, file e27ce431-c41d-2581-e053-d805fe0acbaa 139
SLC22A2 variants and dolutegravir levels correlate with psychiatric symptoms in persons with HIV, file e27ce42d-d3c3-2581-e053-d805fe0acbaa 136
Evaluation of a Cognitive Rehabilitation Protocol in HIV Patients with Associated Neurocognitive Disorders: Efficacy and Stability Over Time, file e27ce427-dc4e-2581-e053-d805fe0acbaa 135
A reduced dose of darunavir/ritonavir is effective in PI-experienced HIV-infected patients., file e27ce429-063f-2581-e053-d805fe0acbaa 135
Elvitegravir/Cobicistat/Tenofovir/Emtricitabine Penetration in the Cerebrospinal Fluid of Three HIV-Positive Patients, file e27ce429-b6a7-2581-e053-d805fe0acbaa 131
Successful pharmacogenetics-based optimization of unboosted atazanavir plasma exposure in HIV-positive patients: a randomized, controlled, pilot study (the REYAGEN study), file e27ce427-493f-2581-e053-d805fe0acbaa 128
Response to First-Line Ritonavir-Boosted Protease Inhibitors (PI/r)-Based Regimens in HIV Positive Patients Presenting to Care with Low CD4 Counts: Data from the Icona Foundation Cohort, file e27ce429-a93c-2581-e053-d805fe0acbaa 128
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus, file e27ce429-bd05-2581-e053-d805fe0acbaa 124
Blood–brain barrier impairment in patients living with hiv: Predictors and associated biomarkers, file e27ce432-7a78-2581-e053-d805fe0acbaa 122
Seminal pharmacokinetics and antiviral efficacy of once-daily maraviroc plus lopinavir/ritonavir in HIV-infected patients., file e27ce426-f675-2581-e053-d805fe0acbaa 121
Antiretroviral therapy in geriatric HIV patients: The GEPPO cohort study, file e27ce42d-649a-2581-e053-d805fe0acbaa 115
Antiretroviral Drug Penetration into the CNS Compartment, file e27ce42a-785b-2581-e053-d805fe0acbaa 109
Prevalence and predictors of blood-brain barrier damage in the HAART era., file e27ce428-ccd6-2581-e053-d805fe0acbaa 106
Prevalence and predictors of long corrected QT interval in HIV-positive patients: a multicenter study, file e27ce42a-5f2a-2581-e053-d805fe0acbaa 99
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort, file e27ce42d-d3bf-2581-e053-d805fe0acbaa 98
Cytomegalovirus central nervous system compartmentalization in a patient presenting with AIDS, file e27ce429-0fa8-2581-e053-d805fe0acbaa 96
Tenofovir and emtricitabine cerebrospinal fluid-to-plasma ratios correlate to the extent of blood-brainbarrier damage., file e27ce426-d682-2581-e053-d805fe0acbaa 94
In-hospital and long-term outcomes of HIV-positive patients undergoing PCI according to kind of stent: a meta-analysis, file e27ce42d-c454-2581-e053-d805fe0acbaa 94
Co-infection with other respiratory pathogens in COVID-19 patients, file e27ce431-c341-2581-e053-d805fe0acbaa 92
The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: A cross sectional study of people aged 65 - 74 years and more than 75 years, file e27ce42d-3fb0-2581-e053-d805fe0acbaa 89
Symptomatic cerebrospinal fluid HIV-1 escape in two patients on second-line antiretroviral therapy in Uganda, file e27ce42d-d3b9-2581-e053-d805fe0acbaa 87
Health-care Associated KPC-BSI: The Time Has Come., file e27ce426-9dc6-2581-e053-d805fe0acbaa 83
The outcome of HIV-positive late presenters according to detectable CMV DNA and anti-CMV treatment, file e27ce42c-7f76-2581-e053-d805fe0acbaa 83
The Italian registry of pulmonary non-tuberculous mycobacteria - IRENE: The study protocol, file e27ce42d-5bb2-2581-e053-d805fe0acbaa 81
Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection, file e27ce432-0f19-2581-e053-d805fe0acbaa 74
Elderly HIV-positive women: A gender-based analysis from the Multicenter Italian “GEPPO” Cohort, file e27ce42f-35ab-2581-e053-d805fe0acbaa 70
Lower dolutegravir plasma concentrations in HIV-positive patients receiving valproic acid, file e27ce42e-f730-2581-e053-d805fe0acbaa 69
Validation of a UHPLC-MS/MS Method to Quantify Twelve Antiretroviral Drugs within Peripheral Blood Mononuclear Cells from People Living with HIV, file e27ce431-312c-2581-e053-d805fe0acbaa 68
Raltegravir penetration in seminal plasma of healthy volunteers., file e27ce426-cc1e-2581-e053-d805fe0acbaa 67
An update on integrase inhibitors: new opportunities for a personalized therapy? The NEXTaim Project, file e27ce427-f7f1-2581-e053-d805fe0acbaa 66
Heart failure in patients with human immunodeficiency virus: a review of the literature., file e27ce428-cee3-2581-e053-d805fe0acbaa 65
Diagnostic SARS-CoV-2 Cycle Threshold Value Predicts Disease Severity, Survival, and Six-Month Sequelae in COVID-19 Symptomatic Patients, file e27ce432-27ed-2581-e053-d805fe0acbaa 63
Anti-CD20 antibody therapy for B-cell lymphomas, file e27ce427-f47e-2581-e053-d805fe0acbaa 61
What do we know about tailoring treatment with tenofovir?, file e27ce429-0a6b-2581-e053-d805fe0acbaa 61
Tenofovir clearance is reduced in hiv-positive patients with subclinical tubular impairment, file e27ce429-b2bb-2581-e053-d805fe0acbaa 61
The symptomatology of cerebrospinal fluid HIV RNA escape: a large case-series, file e27ce435-a66d-2581-e053-d805fe0acbaa 56
Cerebrospinal fluid viral load and neopterin in HIV-positive patients with undetectable viraemia, file e27ce42d-7235-2581-e053-d805fe0acbaa 55
Vitamin D as Modulator of Drug Concentrations: A Study on Two Italian Cohorts of People Living with HIV Administered with Efavirenz, file e27ce433-12a1-2581-e053-d805fe0acbaa 55
The manifesto of pharmacoenosis: Merging hiv pharmacology into pathocoenosis and syndemics in developing countries, file e27ce433-32b1-2581-e053-d805fe0acbaa 55
Ageing with HIV: a multidisciplinary review, file e27ce427-fa89-2581-e053-d805fe0acbaa 51
Analytical validation and clinical application of rapid serological tests for sars-cov-2 suitable for large-scale screening, file e27ce431-e772-2581-e053-d805fe0acbaa 50
Two treatment strategies for management of Neurosymptomatic cerebrospinal fluid HIV escape in Pune, India, file e27ce432-917c-2581-e053-d805fe0acbaa 50
Clinical phenotype and contagiousness of early breakthrough SARS-CoV-2 infections after BNT162b2 COVID-19 mRNA vaccine: A parallel cohort study in healthcare workers, file e27ce434-8c4d-2581-e053-d805fe0acbaa 50
Class-specific relative genetic contribution for key antiretroviral drugs, file e27ce42a-686a-2581-e053-d805fe0acbaa 49
Detectable cerebrospinal fluid JCV DNA in late-presenting HIV-positive patients: beyond progressive multifocal leukoencephalopathy?, file e27ce42d-33fb-2581-e053-d805fe0acbaa 49
Long-Term Suppressive cART Is Not Sufficient to Restore Intestinal Permeability and Gut Microbiota Compositional Changes, file e27ce432-5aca-2581-e053-d805fe0acbaa 49
Cerebrospinal Fluid Inhibitory Quotients of Antiretroviral Drugs in HIV-positive Patients are Associated with Compartmental Viral Control., file e27ce42a-5667-2581-e053-d805fe0acbaa 45
A UPLC-MS-MS method for the simultaneous quantification of first-line antituberculars in plasma and in PBMCs, file e27ce42a-6e2f-2581-e053-d805fe0acbaa 45
Seasonal variation of antiretroviral drug exposure during the year: The experience of 10 years of therapeutic drug monitoring, file e27ce432-ff8c-2581-e053-d805fe0acbaa 45
Low cerebrospinal fluid Amyloid-βeta 1–42 in patients with tuberculous meningitis, file e27ce434-6154-2581-e053-d805fe0acbaa 45
Development and Validation of an Up-to-Date Highly Sensitive UHPLC-MS/MS Method for the Simultaneous Quantification of Current Anti-HIV Nucleoside Analogues in Human Plasma, file e27ce431-d047-2581-e053-d805fe0acbaa 44
Risk for SARS-CoV-2 Infection in Healthcare Workers, Turin, Italy, file e27ce432-7646-2581-e053-d805fe0acbaa 43
Seroprevalence of SARS-CoV-2 Among Workers in Northern Italy, file e27ce433-6306-2581-e053-d805fe0acbaa 43
Lowering SARS-CoV-2 viral load might affect transmission but not disease severity in secondary cases, file e27ce432-218f-2581-e053-d805fe0acbaa 41
Durability of Integrase STrand Inhibitor (InSTI)-based regimen in geriatric people living with HIV in the GEPPO cohort, file e27ce433-32b2-2581-e053-d805fe0acbaa 41
Monthly Increase in Vitamin D Levels upon Supplementation with 2000 IU/Day in Healthy Volunteers: Result from “Integriamoci”, a Pilot Pharmacokinetic Study, file e27ce434-521e-2581-e053-d805fe0acbaa 39
Role of Normalized T-Cell Subsets in Predicting Comorbidities in a Large Cohort of Geriatric HIV-infected Patient, file e27ce42d-4014-2581-e053-d805fe0acbaa 38
Patterns of Cerebrospinal Fluid Alzheimer’s Dementia Biomarkers in People Living with HIV: Cross-Sectional Study on Associated Factors According to Viral Control, Neurological Confounders and Neurocognition, file e27ce435-6124-2581-e053-d805fe0acbaa 37
Pharmacogenetic determinants of kidney-associated urinary and serum abnormalities in antiretroviral-treated HIV-positive patients, file e27ce42f-7b61-2581-e053-d805fe0acbaa 36
Low antituberculosis drug concentrations in HIV-tuberculosis-coinfected adults with low body weight: Is it time to update dosing guidelines?, file e27ce42e-19ea-2581-e053-d805fe0acbaa 34
Tuberculosis and COVID-19 co-infection: description of the global cohort, file e27ce434-6037-2581-e053-d805fe0acbaa 34
Intracellular accumulation of atazanavir/ritonavir according to plasma concentrations and OATP1B1, ABCB1 and PXR genetic polymorphisms., file e27ce42a-40fa-2581-e053-d805fe0acbaa 33
The Influence of Pharmacogenetic Variants in HIV/Tuberculosis Co-infected Patients in Uganda in the SOUTH Study, file e27ce42f-23cd-2581-e053-d805fe0acbaa 32
Serology for Borrelia spp. in Northwest Italy: A Climate-Matched 10-Year Trend, file e27ce434-7e3f-2581-e053-d805fe0acbaa 32
Medication Burden and Clustering in People Living with HIV Undergoing Therapeutic Drug Monitoring, file e27ce435-8569-2581-e053-d805fe0acbaa 30
Cognitive Rehabilitation Protocol in HIV/AIDS Outpatients with ANI and MND: a pilot study, file e27ce427-ebc3-2581-e053-d805fe0acbaa 29
The good, the bad and the ugly: Determinants of antiretroviral-associated toxicities, file e27ce428-cccd-2581-e053-d805fe0acbaa 27
SLC22A2 variants and dolutegravir levels correlate with psychiatric symptoms in persons with HIV, file e27ce435-810a-2581-e053-d805fe0acbaa 27
High incidence of infections in HIV-positive patients treated for lymphoproliferative disorders, file e27ce42d-6343-2581-e053-d805fe0acbaa 26
Etravirine Plasma Exposure is Associated with Virological Efficacy in Treatment-experienced HIV-positive Patients., file e27ce42a-195b-2581-e053-d805fe0acbaa 24
Efficacy, safety and pharmacokinetics of atazanavir (200mg twice daily) plus raltegravir (400mg twice daily) dual regimen in the clinical setting, file e27ce42a-e313-2581-e053-d805fe0acbaa 24
Circulating angiopoietin-like protein 2 levels are associated with decreased renal function in HIV + subjects on cART: A potential marker of kidney disease, file e27ce42d-d3bd-2581-e053-d805fe0acbaa 24
Totale 12.790
Categoria #
all - tutte 20.820
article - articoli 0
book - libri 0
conference - conferenze 105
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.925


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019611 0 0 0 0 0 0 0 0 0 0 359 252
2019/20202.178 201 190 115 297 167 163 170 220 232 150 131 142
2020/20211.840 108 133 99 88 184 189 123 165 137 202 159 253
2021/20222.727 273 174 170 304 247 125 231 152 160 155 508 228
2022/20232.031 93 159 474 315 122 161 134 155 157 93 115 53
2023/20242.080 75 64 96 54 93 65 218 830 164 216 205 0
Totale 13.454